| Describe the common nomenclature and definitions of dry needling used to treat trigger points/myofascial pain. |
|
|
|
|
|
|
|
| Define the indications, contraindications, precautions, and possible adverse reactions that clinicians should consider when determining if a patient is an appropriate candidate for trigger point dry needling. |
|
|
|
|
|
|
|
| Differentiate acupuncture vs. dry needling treatment theories and physiology concepts that should be explained to patients during the consent and education processes in the clinical setting. |
|
|
|
|
|
|
|
| Analyze a thorough literature review of available medical evidence for and against trigger point dry needling in the management of musculoskeletal conditions. |
|
|
|
|
|
|
|
| Identify the administrative requirements and best practices for training, certification, clinical documentation, preceptorship, and privileging in the US military health system according to current policies and/or regulations. |
|
|
|
|
|
|
|
| Utilize functional tests, standard precautions, and appropriate informed consent procedures to safely perform trigger point dry needling techniques to minimize risk of any possible adverse events. |
|
|
|
|
|
|
|
| Practice safe and effective use of percutaneous electrostimulation during a trigger point dry needling session. |
|
|
|
|
|
|
|
| Demonstrate proficiency in appropriate palpation techniques to promote safety and appropriate protection to treatment areas to reduce the risk of an adverse event. |
|
|
|
|
|
|
|